Treatment of haemophilia in the United Kingdom 1981-1996

Haemophilia

Volumn 7, Issue 4, 2001, Pages 349-359

  Rizza, C R ^a   Spooner, R J D ^a   Giangrande, P L F ^a   Hill, ^a,b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 CRYOPRECIPITATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 CONCENTRATE; BLOOD CLOTTING INHIBITOR; DESMOPRESSIN; FIBRINOGEN; PROTHROMBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CAUSE OF DEATH; CHILD; CONGENITAL DISORDER; CONTROLLED STUDY; HEMOPHILIA A; HEMOPHILIA B; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; UNITED KINGDOM; VON WILLEBRAND DISEASE;

DATA COLLECTION; GREAT BRITAIN; HEMOPHILIA A; HUMANS;

EID: 0034913419     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2001.00521.x     Document Type: Article

References (25)

1. Development of a national database to provide information for the planning of care of patients with congenital blood coagulation defects
2. Evidence for existence of at least two types of factor-VIII-associated non-B transfusion hepatitis
3. Prevalance of antibody to HTLVIII in haemophiliacs in the United Kingdom
4. Prevalence of antibody to HIV in haemophiliacs in the United Kingdom: A second survey
5. Seropositivity for HIV in UK haemophiliacs
6. Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: Report on behalf of the directors of haemophilia centres in the United Kingdom
7. Mortality before and after HIV infection in the complete UK population of haemophiliacs
8. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population
9. Mortality from liver cancer and liver disease in haemophilic men and boys in the UK given blood products contaminated with hepatitis C
10. Confirmation of viral safety of dry heated factor VIII concentrate (8Y) prepared by Bio Products Laboratory (BPL): A report on behalf of the UK Haemophilia Centre Directors
11. The incidence of factor VIII inhibitors in the United Kingdom. 1990-93
12. Haemophilia treatment in the United Kingdom from 1969 to 1974
13. First report on UK database of haemophilia B mutations
14. Start of UK confidential haemophilia database: Analysis of 142 patients by solid phase fluorescent chemical cleavage of mismatch
15. Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976-80. Report on behalf of the directors of haemophilia centres in the United Kingdom
16. The obstetric experience of carriers of haemophilia
17. Jaundice and antibodies directed against factors VIII and IX in patients treated for haemophilia or Christmas disease in the United Kingdom
18. Guidelines for the diagnosis and management of von Willebrand disease
19. Rare coagulation disorders
20. Recommendations on choice of therapeutic products for the treatment of patients with haemophilia A, haemophilia B and von Willebrand's disease
21. HIV seroconversion in haemophilic boys receiving heat-treated factor VIII concentrate
22. Carrier testing and prenatal diagnosis for haemophilia: Experiences and attitudes of 549 potential and obligate carriers
23. The increasing prevalence of haemophilia
24. Factor VIII inhibitors in mild and moderate-severity haemophilia A
25. Gene deletions in patients with haemophilia B and anti-factor IX antibodies